Turn scattered studies into a single, persuasive narrative: a value dossier distills every clinical, economic, and organizational proof‑point your MedTech innovation needs to win over clinicians, payers, and HTA bodies.
Innovative devices don’t sell themselves; their value must be crystal‑clear to clinicians, payers, and HTA reviewers alike. That means answering every tough question upfront: Why does this disease matter? Where do current therapies fall short? How big is the unmet need? Is your solution safer, more effective, and more cost‑efficient? And doing it in a single, compelling narrative.
Scattered journal articles and slick brochures leave gaps that stall reimbursement and slow adoption. Our Value Dossier closes those gaps, packaging rock‑solid clinical, economic, and organizational evidence into a format HTA bodies, procurement organizations expect and decision‑makers trust. Use it to justify local business cases today and sail through national assessments tomorrow.
Choose the dossier that matches your launch rhythm:
- Basic Value Dossier – 15‑25 punchy pages laser‑focused on headline data, perfect for investor decks, KOL and procurement briefings, or early payer conversations.
- Core Value Dossier – 50-70 pages (plus appendices) of deep‑dive evidence, ready to underpin full‑scale European or global reimbursement and HTA submissions.
Whether you need a fast‑track summary or a comprehensive “no‑stone‑unturned” file, MTRC turns evidence into influence, so your technology wins approval, reimbursement, and market share faster.
What is the typical content of the dossier?
Our approach takes into account both the EUnetHTA Core HTA model, and the format of the typical reimbursement and HTA dossiers in Europe.
Choose Your Perfect Dossier
Three evidence packs: Start-Up, Basic, and Comprehensive, so you always have the right ammunition for every stage of your MedTech journey.
| Feature | Start-up | Basic | Comprehensive |
|---|---|---|---|
| Size, pages | 15 | 25 | 40-60 |
| Appendixes | No | No | Yes |
| PRISMA-compliant reporting | Selective reporting of key publications | Selective reporting of key publications | Yes |
| Timelines, weeks | 4 | 4 - 6 | 12-16 |
| Number of revisions from client | 0 | 1 | 2 |
| Use case | Marketing, sales, procurement, clinical stakeholder engagement | Marketing, sales, procurement, clinical stakeholder engagement | Marketing, sales, procurement, clinical stakeholder engagement, reimbursement, HTA |
| Risk of bias assessment | No | No | Yes, for product studies |
| Communication | No (client fills in request form with detailed PICO) | Kick-off, delivery meeting | Kick-off, delivery meeting, bi-weekly updates by email or TC |
| Price, euros | 12,500 | 19,500 | On request (x2-3) |
Global, European
or country-specific dossiers
Usually, dossiers are developed from a global or European perspective, which means that the selection of epidemiological data, treatment patterns, patient pathways and other data is based primarily on either global or European sources.
Clinical effectiveness data are always based on global evidence.
The scope of the dossier is discussed with the client to adjust the methodological approach. In some cases, MTRC will limit the data to key European markets (e.g., EU5 – France, Germany, Italy, Spain, and the UK).
Our team can apply our deep knowledge of the requirements of different reimbursement and Health Technology Assessment stakeholders in Europe to ensure that our clients receive a truly useful value dossier. MTRC has worked on reimbursement/HTA submission projects in Belgium, France, Germany, Italy, Norway, the Netherlands, Poland, Russia, Sweden, and the UK.
Get insights from MTRC free analytical reports
Explore free MTRC analytical reports and white papers for in-depth insights into value dossier development and value communication for medical technologies in Europe
Explore MTRC research papers:
- Value Dossiers for Medical Technologies: What, When and How? (Report #12)
- Best Reporting Checklists for Studies of Medical Devices (Report #20)
- Challenges of HTA and Reimbursement Submissions for Medical Devices (Report #18)
- Challenges and Proposed Solutions in SLR for Medical Devices (Report #15)
- Evidence Gap Analysis for Medical Technologies in Europe – a Practical Example (Report #3)
MTRC in numbers
An extremely specialised boutique consultancy with a global impact
Get in touch
Contact us to discuss your needs and learn about our services